Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Somatropin
Drug ID BADD_D02055
Description Human growth hormone (HGH), also known as somatotropin, is a peptide hormone that is synthesized and secreted by the somatotropic cells of the anterior pituitary gland.[A228183] Growth hormone plays an essential role in growth regulation during childhood as well as other basal metabolic functions, muscle and fat mass regulation, blood glucose level regulation, and lipid regulation in both children and adults.[A228183, L31508] Synthesized in a strain of _Escherichia coli_, recombinant HGH is a polypeptide hormone that contains 191 amino acid residues with a molecular weight of 22 kDa. It has an identical primary protein structure to endogenous human growth hormone.[A228188] Recombinant HGH has been commercially available since 1985 after its development by Genentech. [Somatrem] was the first available recombinant HGH and was largely replaced by somatropin, another form of recombinant HGH.[A228183] Growth hormone therapy is approved for various disorders of growth hormone deficiency, growth failure, or short stature including Turner syndrome, chronic renal insufficiency before transplantation, Prader-Willi syndrome, a history of fetal growth restriction, short stature homeobox (SHOX) haploinsufficiency, Noonan syndrome, idiopathic short stature, and adult- or childhood-onset growth hormone deficiency.[A228188] Recombinant growth hormone is available as a subcutaneous injection for children and adults under a wide variety of brand names.
Indications and Usage For treatment of dwarfism, acromegaly and prevention of HIV-induced weight loss
Marketing Status Prescription; Discontinued
ATC Code H01AC01
DrugBank ID DB00052
KEGG ID D02691
MeSH ID D019382
PubChem ID Not Available
TTD Drug ID D09DMQ
NDC Product Code 55566-1902; 44087-0004; 62287-190; 44087-0006; 55566-1901; 0002-8149; 50242-075; 0013-2655; 0013-2626; 44087-3388; 68594-040; 0002-8148; 0002-8147; 0013-2650; 0169-7705; 0781-4004; 0013-2653; 0013-2649; 0013-2658; 50242-076; 0013-2646; 0013-2656; 50242-074; 44087-0005; 0781-3001; 44087-1005; 55566-1801; 44087-0016; 0013-2652; 0169-7708; 50242-931; 0013-2654; 0013-2651; 0169-7704; 0781-3004; 44087-1088; 0013-2657; 0169-7703; 57831-0423
Synonyms Human Growth Hormone | Growth Hormone, Human | hGH (Human Growth Hormone) | Somatropin (Human) | Somatotropin (Human) | Somatropin | Serostim | Zomacton | Cryo-Tropin | Cryo Tropin | CryoTropin | Recombinant Human Growth Hormone (Mammalian) | r-hGH-M | r-hGH(m) | Humatrope | Umatrope | Maxomat | Norditropin | Norditropin Simplexx | Norditropine | Nutropin | Omnitrope | Saizen | Genotropin | Genotonorm
Chemical Information
Molecular Formula Not Available
CAS Registry Number 12629-01-5
SMILES Not Available
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Haemorrhoids24.10.02.002; 07.15.03.001--
Headache17.14.01.001--
Hepatic function abnormal09.01.02.001--Not Available
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hypersensitivity10.01.03.003--
Hypomagnesaemia14.04.02.001--
Infection11.01.08.002--Not Available
Influenza like illness08.01.03.010--
Injection site inflammation12.07.03.009; 08.02.03.008--Not Available
Injection site pain12.07.03.011; 08.02.03.010--Not Available
Injection site reaction12.07.03.015; 08.02.03.014--
Insomnia19.02.01.002; 17.15.03.002--
Laryngitis11.01.13.001; 22.07.03.001--
Malaise08.01.01.003--
Melaena24.07.02.013; 07.12.02.004--Not Available
Muscle spasms15.05.03.004--
Myalgia15.05.02.001--
Nail disorder23.02.05.002--
Nausea07.01.07.001--
Nephrolithiasis20.04.01.002--
Oedema14.05.06.010; 08.01.07.006--Not Available
Oedema peripheral14.05.06.011; 08.01.07.007; 02.05.04.007--
Pain08.01.08.004--
Pancreatitis07.18.01.001--
Paraesthesia17.02.06.005--
Periorbital oedema23.04.01.002; 10.01.05.010; 06.08.03.017--
Pharyngitis11.01.13.003; 07.05.07.004; 22.07.03.004--
Prothrombin level decreased13.01.02.010--Not Available
Pruritus23.03.12.001--
Purpura24.07.06.005; 23.06.01.004; 01.01.04.003--
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages